Search
Search Results
##search.searchResults.foundPlural##
-
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
3299PDF: 1959HTML: 7472 -
ENDOTHELIAL BIOMARKERS IN PATIENTS RECOVERED FROM COVID-19 ONE YEAR AFTER HOSPITAL DISCHARGE: A CROSS-SECTIONAL STUDY Endothelial biomarkers in COVID-19 recoverers one year after hospital discharge.
1268PDF: 718HTML: 319 -
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
3990PDF: 1048HTML: 3588Untitled: 175Cneo. Fig.1: 112Untitled: 103Untitled: 126Untitled: 130 -
CD48 AS A NOVEL EARLY BIOMARKER COMPLEMENTING PROCALCITONIN AND LACTATE FOR PREDICTING BACTEREMIA IN PEDIATRIC FEBRILE NEUTROPENIA: A PROSPECTIVE COHORT STUDY CD48 A NOVEL EARLY BIOMARKER PREDICTING BACTERIEMIA
840PDF: 588HTML: 108 -
HEPARIN-BINDING PROTEIN AS A DIAGNOSTIC AND PROGNOSTIC MARKER OF INFECTIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS Heparin-binding protein in adult patients
2183PDF: 986HTML: 144Suppl. Files: 510 -
ASSESSMENT OF THE EFFICACY OF PROCALCITONIN, C-REACTIVE PROTEIN AND ALBUMIN LEVELS-GUIDED ANTIBIOTICS USE IN SEPSIS
924PDF: 495Html: 142Suppl. Files: 172 -
DIAGNOSIS OF MALARIA INFECTION WITH OR WITHOUT DISEASE
3597PDF: 1106HTML: 23334 -
ASSOCIATION BETWEEN PRE-ADMISSION 48-HOUR FEVER BURDEN AND OUTCOMES IN PEDIATRIC MYCOPLASMA PNEUMONIAE INFECTION PRE-ADMISSION 48-HOUR FEVER BURDEN AND OUTCOMES IN PEDIATRIC MYCOPLASMA PNEUMONIAE
132PDF: 151Suppl. Files: 29HTML: 17 -
THE SPECTRUM OF GENETIC DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2233PDF: 879HTML: 1999Fig 1 Rossi: 176 -
EVALUATION OF THE PLASMA MICRO RNA EXPRESSION LEVELS IN SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
1384PDF: 685HTML: 1079Untitled: 179Untitled: 149Untitled: 130Untitled: 151Untitled: 161 -
-
COMPARISON OF IL-34, ELASTOGRAPHY, AND BIOPSY IN THE ASSESSMENT OF LIVER FIBROSIS IN CHRONIC HEPATITIS B Evaluating Non-Invasive and Invasive Methods in Liver Fibrosis
525PDF: 284Html: 23 -
EFFICACY OF VENETOCLAX COMBINED WITH AZACITIDINE IN ELDERLY PATIENTS WITH RELAPSED ACUTE MYELOID LEUKEMIA
1450PDF: 757Suppl. Files: 320Html: 134 -
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
4714PDF: 1549HTML: 2251Untitled: 206Untitled: 222Untitled: 230Untitled: 212Untitled: 214 -
PROCALCITONIN AS A BIOMARKER OF BACTERIAL INFECTION IN SICKLE CELL VASO-OCCLUSIVE CRISIS.
2062PDF: 1042HTML: 15650COVER LETTER: 187 -
CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA CAR T Cells and Myeloma Treatment
1707PDF: 832HTML: 143 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3674PDF: 1435HTML: 181 -
IS IT POSSIBLE TO PREDICT TUMOR PROGRESSION THROUGH GENOMIC CHARACTERIZATION OF MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA? MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA
2538PDF: 1127HTML: 138 -
PREVALENCE OF ANEMIA, IRON DEFICIENCY, AND IRON DEFICIENCY ANEMIA AND DIAGNOSTIC PERFORMANCE OF HEMATOLOGIC AND BIOCHEMICAL MARKERS OF SIDEROPENIA IN 1- TO 5-YEAR-OLD CHILDREN IN THRACE GREECE Prevalence of ID, IDA and anemia in Greek Thrace
1973PDF: 816HTML: 276 -
Early Diagnosis of Gaucher Disease and ASMD in Sardinia: the “ICHNOS” Project
616PDF: 492Suppl. Files: 126Html: 126 -
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis
1953PDF: 811HTML: 220 -
ASSESSMENT OF DIAGNOSTIC TECHNIQUES OF URINARY TUBERCULOSIS
2004PDF: 773HTML: 2322Untitled: 210 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2180PDF: 1479HTML: 263 -
-
EARLY PREDICTIVE VALUE OF PERIPHERAL INFLAMMATORY INDEX COMBINED WITH HIGH-SENSITIVITY TROPONIN T FOR SEPSIS-INDUCED CARDIOMYOPATHY Inflammatory and Troponon T in cardiomyopaty from Sepsis
168PDF: 178HTML: 12 -
TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML
1032PDF: 1152Suppl. Files: 569HTML: 83 -
MOLECULAR MECHANISMS OF INHIBITOR DEVELOPMENT IN HEMOPHILIA Guest Editor: Giancarlo Costaman
3232PDF: 1609HTML: 424 -
ROLE OF CYTOKINES AS MOLECULAR MARKER OF DENGUE SEVERITY
3166PDF: 1149HTML: 394 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2105PDF: 1685HTML: 374 -
PROLIFERATION AND APOPTOSIS OF B-CELL LYMPHOMA CELLS UNDER TARGETED REGULATION OF FOXO3 BY miR-155 miR-155, FOXO3, B-cell lymphoma, proliferation, apoptosis, clinical characteristics
764PDF: 84HTML: 135







